2,4-Difluoro-N-(2-methoxy-5-(3-oxo-4-(pyridin-4-ylmethyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)pyridin-3-yl)benzenesulfonamide

ID: ALA4244021

PubChem CID: 145984030

Max Phase: Preclinical

Molecular Formula: C26H20F2N4O5S

Molecular Weight: 538.53

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ncc(-c2ccc3c(c2)N(Cc2ccncc2)C(=O)CO3)cc1NS(=O)(=O)c1ccc(F)cc1F

Standard InChI:  InChI=1S/C26H20F2N4O5S/c1-36-26-21(31-38(34,35)24-5-3-19(27)12-20(24)28)10-18(13-30-26)17-2-4-23-22(11-17)32(25(33)15-37-23)14-16-6-8-29-9-7-16/h2-13,31H,14-15H2,1H3

Standard InChI Key:  AJJIMBIWPUTLAP-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
    1.2667  -11.4332    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6833  -10.7208    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.8579  -10.7161    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6875  -12.3749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6875  -13.1999    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3995  -13.6082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1115  -13.1999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1115  -12.3749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3995  -11.9582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8249  -13.6168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8217  -14.4427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5314  -14.8562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5378  -13.2043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2522  -13.6223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2455  -14.4500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9549  -14.8673    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6756  -14.4615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6824  -13.6339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9683  -13.2120    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4006  -13.2279    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3995  -11.1333    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6850   -9.8958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4062   -9.4845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4067   -8.6603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6916   -8.2528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9748   -8.6639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9779   -9.4868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9718  -11.9644    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2585  -12.3790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9739  -12.3870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6911  -11.9793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1195   -9.8991    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.6905   -7.4302    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.4023  -12.3989    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1191  -11.9919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1250  -11.1661    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4083  -10.7489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6945  -11.1583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  4  9  2  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
 10 11  1  0
 10 13  2  0
 11 12  2  0
 12 15  1  0
 14 13  1  0
  7 10  1  0
 14 15  2  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
  9 21  1  0
 21  2  1  0
  2 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
  4 28  1  0
 28 29  1  0
 19 30  1  0
 30 31  1  0
 23 32  1  0
 25 33  1  0
 31 34  2  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 38 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4244021

    ---

Associated Targets(Human)

SNU-638 (372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 538.53Molecular Weight (Monoisotopic): 538.1122AlogP: 4.16#Rotatable Bonds: 7
Polar Surface Area: 110.72Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 6.59CX Basic pKa: 5.01CX LogP: 2.64CX LogD: 2.13
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.38Np Likeness Score: -1.84

References

1. Dong FD, Liu DD, Deng CL, Qin XC, Chen K, Wang J, Song HR, Ding HW..  (2018)  Design, synthesis and biological evaluation of novel series of 2H-benzo[b][1,4]oxazin-3(4H)-one and 2H-benzo[b][1,4]oxazine scaffold derivatives as PI3Kα inhibitors.,  26  (14): [PMID:29937355] [10.1016/j.bmc.2018.06.022]

Source